Latest SEC Filings

Bristow Group Inc.Bristow Group Reports 9.4% Revenue Growth to $411.8 Million in Q2 2026

ACADIA PHARMACEUTICALS INCACADIA Pharmaceuticals Reports 16.4% Revenue Growth to $308M in Q2 2026

Ultragenyx Pharmaceutical Inc.Ultragenyx Reports $214 Million Revenue in Q2 2026, Net Loss of $92 Million

Atlas Energy Solutions Inc.Atlas Energy Solutions Reports Q2 2026 Financial Results with $293.2M Revenue and Increased Net Loss

Cricut, Inc.Cricut Reports Q2 2026 Revenue of $156.3M, Net Income of $39.1M

Primoris Services CorpPrimoris Services Corporation Reports 10.7% Revenue Decline in Q2 2026

TALOS ENERGY INC.Talos Energy Reports 56.5% Revenue Increase to $664.8 Million in Q2 2026

GRAN TIERRA ENERGY INC.Gran Tierra Energy Reports $24.9 Million Net Income in Q2 2026, Driven by 25% Sales Increase

AMGEN INCAmgen Reports 10% Revenue Growth to $10.054 Billion in Latest Quarter

DORIAN LPG LTD.Dorian LPG Reports 123.1% Revenue Growth to $187.9 Million in Latest Quarter

Toast, Inc.Toast, Inc. Reports 23% Revenue Growth to $1.908 Billion in Latest Quarter

Arista Networks, Inc.Arista Networks Reports 37.7% Revenue Growth to $3.036 Billion in Latest Quarter

Astera Labs, Inc.Astera Labs Reports 104% Revenue Growth to $392.4 Million in Latest Quarter

Clear Channel Outdoor Holdings, Inc.Clear Channel Outdoor Reports 8.7% Revenue Growth in Q2 2026 Despite Net Loss

ADVANCED MICRO DEVICES INCAMD Reports 50% Revenue Growth to $11.5 Billion in Latest Quarter

LIFECORE BIOMEDICAL, INC. \DE\Lifecore Biomedical Reports Decline in Revenue and Increased Net Loss for Q2 2026

NCR Atleos CorpNCR Atleos Reports Q2 2026 Financial Results with Revenue of $1.10 Billion and 67% Increase in Net Income

NISOURCE INC.NiSource Reports Q2 2026 Revenue Growth to $1.34 Billion, Net Income Decline

Verano Holdings Corp.Verano Holdings Reports 8% Revenue Growth to $217.9 Million in Q2 2026

Kymera Therapeutics, Inc.Kymera Therapeutics Reports $65M Collaboration Revenue in Q2 2026, Net Loss of $61.2M

Walt Disney CoThe Walt Disney Company Reports $25.2 Billion Revenue with 7% Increase, Net Income Declines 50%

LEMAITRE VASCULAR INCLeMaitre Vascular Reports 10% Revenue Growth to $70.4 Million in Q2 2026

UNITED THERAPEUTICS CorpUnited Therapeutics Reports Q2 2026 Financial Results with Revenue Decline and Increased Net Income

CVS HEALTH CorpCVS Health Reports 7.3% Revenue Growth to $106.1 Billion in Latest Quarter

Dynatrace, Inc.Dynatrace Reports 16% Revenue Growth to $554.5 Million in Q1 Fiscal 2027